Skip to main content
SpringerLink
Log in
Book cover

Applied Physiology in Intensive Care Medicine pp 261–272Cite as

Acute right ventricular failure—from pathophysiology to new treatments

  • Chapter
  • First Online:

Abstract

The right ventricle (RV) provides sustained low-pressure perfusion of the pulmonary vasculature, but is sensitive to changes in loading conditions and intrinsic contractility. Factors that affect right ventricular preload, afterload or left ventricular function can adversely influence the functioning of the RV, causing ischaemia and right ventricular failure (RVF). As RVF progresses, a pronounced tricuspid regurgitation further decreases cardiac output and worsens organ congestion. This can degenerate into an irreversible vicious cycle.

The effective diagnosis of RVF is optimally performed by a combination of techniques including echocardiography and catheterisation, which can also be used to monitor treatment efficacy. Treatment of RVF focuses on alleviating congestion, improving right ventricular contractility and right coronary artery perfusion and reducing right ventricular afterload. As part of the treatment, inhaled nitric oxide or prostacyclin effectively reduces afterload by vasodilating the pulmonary vasculature. Traditional positive inotropic drugs enhance contractility by increasing the intracellular calcium concentration and oxygen consumption of cardiac myocytes, while vasopressors such as norepinephrine increase arterial blood pressure, which improves cardiac perfusion but increases afterload. A new treatment, the calcium sensitiser, levosimendan, increases cardiac contractility without increasing myocardial oxygen demand, while preserving myocardial relaxation. Furthermore, it increases coronary perfusion and decreases afterload. Conversely, traditional treatments of circulatory failure, such as mechanical ventilation and volume loading, could be harmful in the case of RVF. This review outlines the pathophysiology, diagnosis and treatment of RVF, illustrated with clinical case studies.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Starr I, Jeffers WA, Meade RH (1943) The absence of conspicuous increments of venous pressure after severe damage to the RV of the dog, with discussion of the relation between clinical congestive heart failure and heart disease. Am Heart J 26:291–301

    Article  Google Scholar 

  2. Cohen JN, Guiha NH, Broder MJ, Limas CJ (1974) Right ventricular infarction, clinical and hemodynamic features. Am J Cardiol 33:209–214

    Article  Google Scholar 

  3. Health Central – General Encyclopaedia – right-sided heart failure http://www.healthcentral.com/mhc/top/000154.cfm. Accessed June 2002

  4. Kannel WB, Belanger AJ (1991) Epidemiology of heart failure. Am Heart J 121:951–957

    Article  PubMed  CAS  Google Scholar 

  5. Jacobs AK, Leopold JA, Bates E, Mendes LA, Sleeper LA, White H, Davidoff R, Boland J, Modur S, Forman R, Hochman JS (2003) Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. J Am Coll Cardiol 41:1273–1279

    Article  PubMed  Google Scholar 

  6. Mehta SR, Eikelboom JW, Natarajan MK, Diaz R, Yi C, Gibbons RJ, Yusuf S (2001) Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. J Am Coll Cardiol 37:37–43

    Article  PubMed  CAS  Google Scholar 

  7. Lupi-Herrera E, Lasses LA, Cosio-Aranda J, Chuquirue-Valenzuela E, Martinez-Sanchez C, Ortiz P, Gonzalez-Pacheco H, Juarez-Herrera U, Rodriguez Mdel C, Vargas-Barron J, Martinez-Rios MA (2002) Acute right ventricular infarction: clinical spectrum, results of reperfusion therapy and short-term prognosis. Coron Artery Dis 13:57–64

    Article  PubMed  Google Scholar 

  8. Stephanazzi J, Guidon-Attali C, Escarment J (1997) Right ventricular function: physiological and pathophysiological features. Ann Fr Anesth Reanim 16:165–186

    PubMed  CAS  Google Scholar 

  9. Redington AN, Gray JJ, Hodson ME, Rigby ML, Oldershaw PJ (1988) Characterisation of the normal right ventricular pressure-volume relation by biplane angiography and simultaneous micromanometer pressure measurements. Br Heart J 59:23–30

    Article  PubMed  CAS  Google Scholar 

  10. Redington AN, Rigby ML, Shinebourne EA, Oldershaw PJ (1990) Changes in the pressure-volume relation of the right ventricle when its loading conditions are modified. Br Heart J 63:45–49

    Article  PubMed  CAS  Google Scholar 

  11. Matthay RA, Arroliga AC, Wiedemann HP, Schulman DS, Mahler DA (1992) Right ventricular function at rest and during exercise in chronic obstructive pulmonary disease. Chest 101:255S–262S

    PubMed  CAS  Google Scholar 

  12. Brooks H, Kirk ES, Vokonas PS, Urschel CW, Sonnenblick EH (1971) Performance of the right ventricle under stress: relation to right coronary flow. J Clin Invest 50:2176–2183

    Article  PubMed  CAS  Google Scholar 

  13. Vieillard-Baron A, Page B, Augarde R, Prin S, Qandli S, Beauchet A, Dubourg O, Jardin F (2001) Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med 27:1481–1486

    Article  PubMed  CAS  Google Scholar 

  14. Vieillard-Baron A, Prin S, Chergui K, Dubourg O, Jardin F (2002) Echo-Doppler demonstration of acute cor pulmonale at the bedside in the medical intensive care unit. Am J Respir Crit Care Med 166:1310–1319

    Article  PubMed  Google Scholar 

  15. Vieillard-Baron A, Schmitt JM, Augarde R, Fellahi JL, Prin S, Page B, Beauchet A, Jardin F (2001) Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: incidence, clinical implications and prognosis. Crit Care Med 29:1551–1555

    Article  PubMed  CAS  Google Scholar 

  16. Jardin F (2003) Ventricular interdependence: how does it impact on hemodynamic evaluation in clinical practice? Intensive Care Med 29:361–363

    Article  PubMed  Google Scholar 

  17. Visner MC, Arentzen CE, O'Conner MJ, Larson EV, Anderson RW (1983) Alterations in left ventricular three-dimensional dynamic geometry and systolic function during acute right ventricular hypertension in the conscious dog. Circulation 67:353–365

    PubMed  CAS  Google Scholar 

  18. Goto Y, Yamamoto J, Saito M, Haze K, Sumiyoshi T, Fukami K, Hiramori K (1985) Effects of right ventricular ischemia on left ventricular geometry and the end-diastolic pressure-volume relationship in the dog. Circulation 72:1104–1114

    PubMed  CAS  Google Scholar 

  19. Renaud E, Karpati P, Mebazaa A (2002) Acute right ventricular failure: physiology and therapy. In: Vincent J-L (ed) 2002 yearbook of intensive care and emergency medicine Springer, Berlin Heidelberg New York, pp 209–218

    Google Scholar 

  20. Taylor RR, Covell JYW, Sonnenblick EH, Ross J (1967) Dependence of ventricular distensibility on filling of the opposite ventricle. Am J Physiol 218:711–718

    Google Scholar 

  21. Brookes C, Ravn H, White P, Moeldrup U, Oldershaw P, Redington A (1999) Acute right ventricular dilatation in response to ischemia significantly impairs left ventricular systolic performance. Circulation 100:761–767

    PubMed  CAS  Google Scholar 

  22. Santamore WP, Gray LA (1996) Left ventricular contributions to right ventricular systolic function during LVAD support. Ann Thorac Surg 61:350–356

    Article  PubMed  CAS  Google Scholar 

  23. Gatecel C, Mebazaa A, Kong R, Guinard N, Kermarrec M, Matéo J, Payen D (1995) Inhaled nitric oxide improves hepatic tissue oxygenation in right ventricular failure: value of hepatic venous oxygen saturation monitoring. Anesthesiology 82:588–590

    Article  PubMed  CAS  Google Scholar 

  24. Dhainaut JF, Brunet F, Monsallier JF Villemant D, Devaux JY, Konnon M, De Gournay JM, Armaganidis A, Iotti G, Huyghebaert MF, Lanore JJ (1987) Bedside evaluation of right ventricular performance using a rapid computerized thermodilution method. Crit Care Med 15:148–152

    Article  PubMed  CAS  Google Scholar 

  25. Jardin F, Gueret P, Dubourg O, Farcot JC, Margairaz A, Bourdarias J-P (1985) Right ventricular volumes by thermodilution in the adult respiratory distress syndrome. A comparative study using two-dimensional echocardiography as a reference method. Chest 88:34–39

    Article  PubMed  CAS  Google Scholar 

  26. Zwissler B (2000) Acute right heart failure. Etiology-pathophysiology-diagnosis-therapy. Anaesthetist 49:788–808

    CAS  Google Scholar 

  27. Bowers TR, O'Neill WW, Grines C, Pica MC, Safian RD, Goldstein JA (1998) Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med 338:933–940

    Article  PubMed  CAS  Google Scholar 

  28. Potapov EV, Sodian R, Leobe M, Drew T, Dreysse S, Hetzer R (2001) Revascularization of the occluded right coronary artery during left ventricular assist device implantation. J Heart Lung Transplant 20:918–922

    Article  PubMed  CAS  Google Scholar 

  29. Mercat A, Kiehl JLK, Meyer G, Teboul JL, Sors H (1999) Hemodynamics effects of fluid loading in acute massive pulmonary embolism. Crit Care Med 27:540–544

    Article  PubMed  CAS  Google Scholar 

  30. Sibbald WJ, Driedger AA (1983) Right ventricular function in acute disease states: pathophysiologic considerations. Crit Care Med 11:339–345

    Article  PubMed  CAS  Google Scholar 

  31. Bundgaard H, Boesgaard S, Mortensen SA, Arendrup H, Aldershvile J (1997) Effect of nitroglycerin in patients with increased pulmonary vascular resistance undergoing cardiac transplantation Scand Cardiovasc J 31:339–342

    Article  PubMed  CAS  Google Scholar 

  32. Vincent JL, Carlier E, Pinsky MR, Goldstein J, Naeije R, Lejeune P, Brimioulle S, Leclerc JL, Kahn RJ, Primo G (1992) Prostaglandin E1 infusion for right ventricular failure after cardiac transplantation. J Thorac Cardiovasc Surg 103:33–39

    PubMed  CAS  Google Scholar 

  33. Packer M (1985) Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards. Ann Intern Med 103:258–270

    CAS  Google Scholar 

  34. Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H, Weissmann N, Gunther A, Walmrath D, Seeger W, Grimminger F (2002) Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet 360:895–900

    Article  PubMed  CAS  Google Scholar 

  35. Langer F, Wendler O, Wilhelm W, Tscholl D, Schafers HJ (2001) Treatment of a case of acute right heart failure by inhalation of iloprost, a long-acting prostacylclin analogue. Eur J Anaestheiol 18:770–773

    CAS  Google Scholar 

  36. Haraldsson A, Kieler-Jensen N, Ricksten SE (1996) Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmaco-dynamic study. J Cardiothorac Vasc Anesth 10:864–868

    Article  PubMed  CAS  Google Scholar 

  37. Mosquera I, Crespo-Leiro MG, Tabuyo T, Paniagua MJ, Fuente L, Bouzas B, Fojon S, Pastor J, Juffe-Stein A, Castro-Beiras A (2002) Pulmonary hypertension and right ventricular failure after heart transplantation: usefulness of nitric oxide. Transplant Proc 34:166–167

    Article  PubMed  CAS  Google Scholar 

  38. Christenson J, Lavoie A, O'Connor M, Bhorade S, Pohlman A, Hall JB (2000) The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Crit Care Med 161:1443–1449

    PubMed  CAS  Google Scholar 

  39. Borade S, Christenson J, O'Connor M, Lavoie A, Pohlman A, Hall JB (1999) Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Respir Crit Care Med 159:571–579

    Google Scholar 

  40. Palhares DB, Figueiredo CS, Moura AJ (1998) Endotracheal inhalatory sodium nitroprusside in severely hypoxic newborns. J Perinat Med 26:219–224

    Article  PubMed  CAS  Google Scholar 

  41. De Backer D, Moures JM, Vachiery JL, Leclerc JL, Kahn RJ, Vincent JL (1996) Oxygenation improvement with nitric oxide in right-to-left shunt without significant effects on pulmonary arterial pressure. Chest 110:1361–1363

    Article  PubMed  CAS  Google Scholar 

  42. Cholley BP, Guinard N, Mateo J, Payen D (1998) Improvement of extreme hypoxemia during end-stage congenital heart disease using nasal nitric oxide. Anesthesiology 89:1586–1587

    Article  PubMed  CAS  Google Scholar 

  43. Lowson SM, Doctor A, Walsh BK, Doorley PA (2002) Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery. Crit Care Med 30:2762–2764

    Article  PubMed  CAS  Google Scholar 

  44. Lowson SM (2002) Inhaled alternatives to nitric oxide. Anesthesiology 96:1504–1513

    Article  PubMed  CAS  Google Scholar 

  45. Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, Niedermeyer J, Fabel H, Seeger W (2000) A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. J Am Coll Cardiol 36:176–182

    Article  Google Scholar 

  46. Curtis JJ, McKenney-Knox CA, Wagner-Mann CC (2002) Postcardiotomy centrifugal assist: a single surgeon's experience. Artif Organs 26:994–997

    Article  PubMed  Google Scholar 

  47. Packer M, Leier CV (1987) Survival in congestive heart failure during treatment with drugs with positive inotropic actions. Circulation 75 (Suppl IV): 55–63

    Google Scholar 

  48. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tandon PK, DeMets DL for the PROMISE study Research Group (1991) Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 352:1468–1475

    Google Scholar 

  49. The Xamoterol in Severe Heart Failure Study Group (1990) Xamoterol in severe heart failure. Lancet 336:1–6

    Google Scholar 

  50. O'Connor CM, Gattis WA, Uretsky BF, Adams KF Jr, McNulty SE, Grossman SH, McKenna WJ, Zannad F, Swedberg K, Gheorghiade M, Califf RM (1999) Continuous intravenous dobut-amine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 138:78–86

    Article  PubMed  Google Scholar 

  51. Unverferth DA, Blanford M, Kates RE, Leier CV (1980) Tolerance to dobutamine after a 72 hour continuous infusion. Am J Med 69:262–266

    Article  PubMed  CAS  Google Scholar 

  52. Haikala H, Nissinen E, Etemadzadeh E, Kevijoki J, Linden I-B (1995) Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol 25:794–801

    Article  PubMed  CAS  Google Scholar 

  53. Ukkonen H, Saraste M, Akkila J, Knuuti MJ, Karanko M, Iida H, Lehikoinen P, Nagren K, Lehtonen L, Voipio-Pulkki LM (2000) Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 68:522–531

    Article  PubMed  CAS  Google Scholar 

  54. Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N (1997) Levosimendan, a novel calcium sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes. Eur J Pharmacol 333:249–259

    Article  PubMed  CAS  Google Scholar 

  55. Slawsky MT, Colucci WS, Gottlieb SS (2000) Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation 102:2222–2227

    PubMed  CAS  Google Scholar 

  56. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 20:196–202

    Article  Google Scholar 

  57. Moiseyev VS, Poder P, Andrejevs N, Ruda MY, Golikov AP, Lazebnik LB, Kobalava ZD, Lehtonen LA, Laine T, Nieminen MS, Lie KI (2002) Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 23:1422–1432

    PubMed  CAS  Google Scholar 

  58. Kivikko M, Antila S, Eha J, Lehtonen L, Pentikainen PJ (2002) Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with sever heart failure. Int J Clin Pharmacol Ther 40:465–471

    PubMed  CAS  Google Scholar 

  59. Molloy WD, Lee KY, Girling L, Schick U, Prewitt RM (1984) Treatment of shock in a canine model of pulmonary embolism. Am Rev Respir Dis 130:870–874

    PubMed  CAS  Google Scholar 

  60. Ghignone M, Girling L, Prewitt RM (1984) Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology 60:132–135

    Article  PubMed  CAS  Google Scholar 

  61. Hirsch LJ, Rooney MW, Wat SS, Kleinmann B, Mathru M (1991) Norepinephrine and phenylephrine effects on right ventricular function in experimental canine pulmonary embolism. Chest 100:796–801

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anaesthesiology and Critical Care Medicine, Hopital Lariboisiére, 2 Rue ambroise Pare, 75475, Paris cedex 10, France

    Alexandre Mebazaa, Peter Karpati & Estelle Renaud

  2. Department of Anaesthesiology–Heart-Lung Division, University Hospital of Lund, 22185, Lund, Sweden

    Lars Algotsson

Authors
  1. Alexandre Mebazaa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Karpati
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Estelle Renaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lars Algotsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2009 Springer-Verlag Berlin Heidelberg

    About this chapter

    Cite this chapter

    Mebazaa, A., Karpati, P., Renaud, E., Algotsson, L. (2009). Acute right ventricular failure—from pathophysiology to new treatments. In: Hedenstierna, G., Mancebo, J., Brochard, L., Pinsky, M. (eds) Applied Physiology in Intensive Care Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01769-8_41

    Download citation

    • DOI: https://doi.org/10.1007/978-3-642-01769-8_41

    • Published:

    • Publisher Name: Springer, Berlin, Heidelberg

    • Print ISBN: 978-3-642-01768-1

    • Online ISBN: 978-3-642-01769-8

    • eBook Packages: MedicineMedicine (R0)

    Publish with us

    Policies and ethics

    Search

    Navigation